The results indicate that genes associated with the poor NB prognosis encode high-ORF dominance transcripts, and OCT4 binding inhibition at the MYCN locus suppresses these high-ORF dominance transcripts in NB. This evidence concerns the gene MYCN and neuroblastoma.